Research Radartracking 1,762 published studies · 471 human · 11 safety signals · 58 clinical trials · 44 cancer pages · updated Sep 2026Open the Research Map →

How we review

How OncoForge builds its pages, who reviews them, and how we keep them honest and current. Educational only; not medical advice.

OncoForge editorial · How we review →

1. The studies are the authority, not us

Every health statement on this site is meant to report what published studies and guidelines describe, with the citation attached. We never tell you something works, cures, prevents, or treats cancer. Where the evidence is early, conflicting, or only from lab or animal studies, we say so. The goal is for a patient, a doctor, and a scientist to read the same page and all trust what it says.

2. How a source-grounded page is built

Our research pages aren't hand-written opinion. For a given subject we search PubMed for the relevant guidelines, reviews, and studies, then an AI model reads them in small batches — using the free full text where it's available, otherwise the abstract, never outside knowledge — and extracts the facts into a strict, structured form (model type, outcome direction, effect sizes, limitations, mechanisms). Every claim must quote the exact sentence from a cited source that supports it, and a deterministic check confirms that quote really appears in that source; a claim whose support can't be found is flagged. A second, stronger AI pass fact-checks each drafted claim against the source text and removes or flags anything the source doesn't support. Then an editor reviews the draft. What may publish before that review happens — and how it is labeled and reversed — is set by a written policy, and section 9 below lists it live.

3. Which sources outrank which

When sources disagree, we don't quietly pick one. A deterministic ranking decides authority: practice guidelines and meta-analyses outrank single randomized trials, which outrank observational studies, which outrank case reports; a retracted source ranks at the bottom. Contradictions are shown on the page, with the more-authoritative source named, so you can see the disagreement instead of having it hidden.

4. Treatment maps: every option, sourced and labeled

Each cancer has a Treatment Map that puts every option in one place, organized by clinical readiness. Established (standard-of-care) treatments are extracted only from authoritative clinical sources — practice guidelines, consensus statements, and meta-analyses — each carrying a verbatim quote we verify against its source, then human-approved before it shows; we reference, but never redistribute, license-restricted guidelines like NCCN. Investigational and adjunct options — every drug, supplement, or repurposed agent the literature studies for that cancer — are placed by how strong their evidence is (tested in people, lab/animal only, or merely named in the literature). Each compound's regulatory status comes from the U.S. FDA's open drug-label data, so it's honestly marked as FDA-approved for that cancer, used off-label, or not an approved drug at all. The map shows what has been studied and how strongly — never a recommendation that anything works.

5. Reported figures: numbers straight from the studies

Where a study reports a quantitative result — a survival time, a hazard ratio, a response or side-effect rate — we capture it as typed data and show it tied to the exact regimen, the comparison group, the patient population, and the number of people in the study, with its source one click away. We copy these numbers; we never average them, never combine figures from different studies, and never turn them into a prediction for any individual. We draw effect sizes as a forest plot — each result a point with its confidence interval on a log scale around the no-difference line — so the uncertainty is visible: a wide interval, or one crossing that line, reads as weak or not significant, and a result with no reported interval is shown as a hollow point. Every mark is computed only from these typed numbers, never from prose, and is labeled in text as well. Doses shown are those used in studies, not a dosing guide. The relevant clinical trials are tracked straight from ClinicalTrials.gov: their status and dates are the registry's own — a trial is shown as completed only when the registry says so, and completed is not the same as positive, so we link the results for you to read. Anything we can't trace to a cited source is dropped, not shown.

6. Kept current, with no drift

Published pages are re-checked against PubMed for retractions and updates. If a cited study is retracted, the claim that relied on it is automatically hidden and the page is flagged for review. Disproven information is never shown. A previously hidden claim stays hidden until a human re-approves it; we never silently re-publish.

7. Honesty enforced in code

The site won't build if a page contains an affiliate link, a fake citation, a prescriptive dose presented as a recommendation, a promissory “cures cancer” claim, marketing/SEO exhaust, a broken internal link, or agent data that drifts from our schema. These are automated checks that run on every build. The editorial standard is part of the code, not a hope.

8. Who reviews

We are not a clinical review board, and we don't claim to be. We are editors who read the sources and approve each page. Curated pages carry a visible “Reviewed” date; source-grounded pages show when they were last approved and when their sources were last checked. None of this replaces your medical team. It's a faithful, cited summary of the literature to bring to them.

9. What publishes without an editor, today

This list is generated from the same settings the publishing code reads, so it changes the moment the policy does (the policy has never been changed from its default: everything waits for an editor).

Studies
Registered human trials and meta-analyses that PubMed itself classes as clinical, that pass every extraction check, and that carry no quality flag publish immediately and are reviewed afterwards. Every other study waits for a person.
Page updates
No cancer-page or topic-page update publishes before an editor reviews it.
Derived surfaces
the pooled-evidence consensus panel and the comparative-effectiveness leaderboard are computed deterministically from figures that were already published and trust-gated, so they refresh without a review step. Clinical-trial status and FDA approval data are mirrored from their registries verbatim.
Everything else
Waits for an editor. Every decision — human or automatic — is logged, and an editor can reverse any automatic one.

Why this exists

OncoForge grew out of one family's search through the research after a rare, aggressive cancer diagnosis: read the story. It's free, ad-free, and sells nothing. See the live research feed and the cancer-type guides.